Melanotan II on TikTok: what the tanning peptide hype leaves out

What did @ninageezzy actually say?

She called melanotan II her "favorite peptide to beat the Winter Blues" and promised that staying tan year-round will make you "feel a little bit better." The core claim is simple: MT2 keeps you tan, tanning makes you feel good, therefore MT2 fixes seasonal low mood. She also said she can "guarantee" the effect.

That guarantee should immediately raise a flag. No responsible clinician guarantees mood outcomes from an unregulated peptide, especially one that has never completed a Phase III clinical trial for any indication. The argument she's making is partly intuitive, which makes it worth unpacking carefully, because some of it is grounded in real biology and some of it is not.

Does the science back this up?

Partly, but not in the way she frames it. Melanotan II is a synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH) that binds melanocortin receptors, including MC1R, which drives pigmentation, and MC3R and MC4R, which are expressed in the brain and involved in mood, appetite, and libido.

There is legitimate preclinical evidence that melanocortin signaling touches dopaminergic and serotonergic pathways. A 2000 paper by Adan and Gispen in the European Journal of Pharmacology reviewed melanocortin receptor subtypes and their central nervous system roles, noting MC4R involvement in mood-adjacent behaviors in rodent models. However, rodent data does not translate cleanly to human seasonal affective disorder. The established treatments for SAD, as reviewed by Lam and Levitt in multiple publications through the Canadian Consensus Guidelines, are light therapy and SSRIs. MT2 does not appear in any of those guidelines. Claiming it treats Winter Blues without that context is a real stretch.

What did they get wrong (or right)?

She gets one thing directionally right: there is a biological connection between melanocortin receptor activity and mood regulation. That is not invented. The MC4R pathway is a real research target and compounds acting on it do affect behavior in animal studies.

But the leap from "MT2 triggers melanocortin receptors" to "MT2 cures your Winter Blues" skips several steps and ignores serious safety concerns. Melanotan II is not FDA-approved for any use. The FDA issued warnings about it in 2018. Studies have documented adverse effects including nausea, spontaneous erections, hyperpigmentation, and, in case reports, changes in existing moles that raised melanoma concerns. A 2011 case series by Dhariwal et al. in the British Journal of Dermatology described dermatological complications in MT2 users. The claim that getting a tan will reliably improve mood is also worth questioning. Tanning beds, which actually deliver UV, have some evidence for mood effects through beta-endorphin release, as shown by Fell et al. in 2014 in Cell. MT2 does not deliver UV. It mimics the downstream signaling without the sun exposure, so even that mechanism is not clearly applicable.

What should you actually know?

MT2 is unregulated, not approved by the FDA, and is sold in a gray market largely through peptide research chemical suppliers. The mood benefit she is describing is speculative at best and not supported by human clinical trial data. The tanning effect itself is real and documented, but it comes with a risk profile that she does not mention at all.

If you are actually dealing with seasonal low mood or diagnosed SAD, the evidence-based options include:

• Light therapy using a 10,000 lux lamp for 20-30 minutes in the morning, supported by multiple randomized controlled trials
• Vitamin D supplementation if deficient, which is common in winter months and has a documented association with mood
• SSRIs, which have Level 1 evidence for SAD per the American Psychiatric Association guidelines

MT2 is not in that list. Buying it from an unverified source and injecting it to feel better in January is not a clinically sound plan. The "you always feel better when you're tan" framing in her caption is also worth noting: that is a subjective belief being dressed up as a pharmacological argument.